Oncology & Cancer

A new molecular target to improve neuroblastoma treatment

The annual mortality rate in childhood cancer of the sympathetic nervous system, or neuroblastoma, is 10 per million between the ages of zero and four. A collaborative work between Basque and Valencian researchers has identified ...

page 10 from 25